J H Meyer1, P P Fang1, T U Krohne1, W M Harmening1, F G Holz1, S Schmitz-Valckenberg2. 1. Universitäts-Augenklinik Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland. 2. Universitäts-Augenklinik Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland. steffen.schmitz-valckenberg@ukb.uni-bonn.de.
Abstract
PURPOSE: Optical coherence tomography angiography (OCT‑A) allows for the non-invasive, three-dimensional visualization of retinal and chorioidal vascular structures. In this study, this new imaging modality was evaluated in rats. METHODS: In vivo imaging in Dark Agouti rats was performed using confocal scanning laser ophthalmoscopy (cSLO) and OCT‑A (Spectralis prototype, Heidelberg Engineering) after adjusting the length of the reference arm. The OCT‑A en-face images were compared to conventional fluorescein angiography cSLO images. The histological examination allowed for correlation of retinal and chorioidal plexus. RESULTS: While the diagnostic device was developed for use in humans, OCT‑A and cSLO imaging can be applied in rodents after only minor hardware modifications. High-resolution and contrast-enhanced images enable a depth-selective visualization of the three retinal plexus and the inner and outer chorioidal vascular networks. In comparison to fluorescein angiography (FA), OCT‑A is characterized by higher resolution and more accurate three-dimensional localization of vascular structures, particularly in deep layers. A current limitation includes the relatively small area imaged by OCT‑A. DISCUSSION: The recently developed OCT‑A imaging technology also allows for three-dimensional detection of retinal and chorioidal vascular changes in vivo without dye injection in rodents. OCT may potentially replace invasive FA for specific questions and will be useful in animal models for research of retinal and chorioidal angiogenic processes physiologically and during pharmacological interventions.
PURPOSE: Optical coherence tomography angiography (OCT‑A) allows for the non-invasive, three-dimensional visualization of retinal and chorioidal vascular structures. In this study, this new imaging modality was evaluated in rats. METHODS: In vivo imaging in Dark Agouti rats was performed using confocal scanning laser ophthalmoscopy (cSLO) and OCT‑A (Spectralis prototype, Heidelberg Engineering) after adjusting the length of the reference arm. The OCT‑A en-face images were compared to conventional fluorescein angiography cSLO images. The histological examination allowed for correlation of retinal and chorioidal plexus. RESULTS: While the diagnostic device was developed for use in humans, OCT‑A and cSLO imaging can be applied in rodents after only minor hardware modifications. High-resolution and contrast-enhanced images enable a depth-selective visualization of the three retinal plexus and the inner and outer chorioidal vascular networks. In comparison to fluorescein angiography (FA), OCT‑A is characterized by higher resolution and more accurate three-dimensional localization of vascular structures, particularly in deep layers. A current limitation includes the relatively small area imaged by OCT‑A. DISCUSSION: The recently developed OCT‑A imaging technology also allows for three-dimensional detection of retinal and chorioidal vascular changes in vivo without dye injection in rodents. OCT may potentially replace invasive FA for specific questions and will be useful in animal models for research of retinal and chorioidal angiogenic processes physiologically and during pharmacological interventions.
Entities:
Keywords:
Fluorescein angiography; In vivo imaging; OCT-angiography; OCT‑A; Rat
Authors: Mathias W Seeliger; Susanne C Beck; Naira Pereyra-Muñoz; Susann Dangel; Jen-Yue Tsai; Ulrich F O Luhmann; Serge A van de Pavert; Jan Wijnholds; Marijana Samardzija; Andreas Wenzel; Eberhart Zrenner; Kristina Narfström; Edda Fahl; Naoyuki Tanimoto; Niyazi Acar; Felix Tonagel Journal: Vision Res Date: 2005-09-26 Impact factor: 1.886
Authors: Nicole Eter; Daniel R Engel; Linda Meyer; Hans-Martin Helb; Felix Roth; Juliane Maurer; Frank G Holz; Christian Kurts Journal: Invest Ophthalmol Vis Sci Date: 2008-03-03 Impact factor: 4.799
Authors: Johanna H Meyer; Alexander Cunea; Kai Licha; Pia Welker; Dagmar Sonntag-Bensch; Paul Wafula; Jens Dernedde; Rolf Fimmers; Frank G Holz; Steffen Schmitz-Valckenberg Journal: Invest Ophthalmol Vis Sci Date: 2016-02 Impact factor: 4.799
Authors: Steffen Schmitz-Valckenberg; Li Guo; Annelie Maass; William Cheung; Anthony Vugler; Stephen E Moss; Peter M G Munro; Frederick W Fitzke; M Francesca Cordeiro Journal: Invest Ophthalmol Vis Sci Date: 2008-02-15 Impact factor: 4.799
Authors: Johanna Meyer; Alexander Cunea; Dagmar Sonntag-Bensch; Pia Welker; Kai Licha; Frank G Holz; Steffen Schmitz-Valckenberg Journal: Invest Ophthalmol Vis Sci Date: 2014-09-04 Impact factor: 4.799
Authors: WooJhon Choi; Kathrin J Mohler; Benjamin Potsaid; Chen D Lu; Jonathan J Liu; Vijaysekhar Jayaraman; Alex E Cable; Jay S Duker; Robert Huber; James G Fujimoto Journal: PLoS One Date: 2013-12-11 Impact factor: 3.240
Authors: Johanna H Meyer; Janine Marx; Claudine Strack; Frank G Holz; Steffen Schmitz-Valckenberg Journal: Transl Vis Sci Technol Date: 2020-06-25 Impact factor: 3.283